Skip to main content
Article thumbnail
Location of Repository

Elicitation of Expert Prior Opinion : Application to the MYPAN Trial in Childhood Polyarteritis Nodosa

By Lisa V. Hampson, John Whitehead, Despina Eleftheriou, Catrin Tudur-Smith, Rachel Jones, David Jayne, Helen Hickey, Michael W. Beresford, Claudia Bracaglia, Afonso Caldas, Rolando Cimaz, Joke Dehoorne, Pavla Dolezalova, Mark Friswell, Marija Jelusic, Stephen D. Marks, Neil Martin, Anne-Marie McMahon, Joachim Peitz, Annet van Royen, Oguz Soylemezoglu and Paul A. Brogan

Abstract

Objectives Definitive sample sizes for clinical trials in rare diseases are usually infeasible. Bayesian methodology can be used to maximise what is learnt from clinical trials in these circumstances. We elicited expert prior opinion for a future Bayesian randomised controlled trial for a rare inflammatory paediatric disease, polyarteritis nodosa (MYPAN, Mycophenolate mofetil for polyarteritis nodosa). Methods A Bayesian prior elicitation meeting was convened. Opinion was sought on the probability that a patient in the MYPAN trial treated with cyclophosphamide would achieve disease remission within 6-months, and on the relative efficacies of mycophenolate mofetil and cyclophosphamide. Expert opinion was combined with previously unseen data from a recently completed randomised controlled trial in ANCA associated vasculitis. Results A pan-European group of fifteen experts participated in the elicitation meeting. Consensus expert prior opinion was that the most likely rates of disease remission within 6 months on cyclophosphamide or mycophenolate mofetil were 74% and 71%, respectively. This prior opinion will now be taken forward and will be modified to formulate a Bayesian posterior opinion once the MYPAN trial data from 40 patients randomised 1: 1 to either CYC or MMF become available. Conclusions We suggest that the methodological template we propose could be applied to trial design for other rare diseases

Topics: CHURG-STRAUSS-SYNDROME, POOR-PROGNOSIS FACTORS, RARE DISEASES, MICROSCOPIC POLYANGIITIS, PULSE CYCLOPHOSPHAMIDE, RANDOMIZED-TRIAL, CLINICAL-TRIALS, VASCULITIS, BELIEFS
Year: 2015
OAI identifier: oai:dspace.library.uu.nl:1874/332852
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://dspace.library.uu.nl:80... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.